Medical devices, healthcare technology and the business of care
510(k) clearance · K261795

Quicktome Software Suite

Omniscient Neurotechnology Pty, Ltd. · Decision date Sep 10, 2026

MEDTECHLEDGER EXPLANATIONK261795

What did the FDA decide?

The FDA recorded a substantial equivalence decision dated September 10, 2026 for K261795, the Quicktome Software Suite submitted by Omniscient Neurotechnology Pty, Ltd. under product code QIH (regulation 21 CFR 892.2050, Class II). The submission was dated August 6, 2026 and received August 7, 2026. The primary predicate listed is K241083, the SIS System, also under QIH. Substantial equivalence is a clearance finding, not approval of a premarket approval application.

The described device is software-only and cloud-deployed, covering DICOM viewing, image fusion, 3D visualization, diffusion-weighted tract mapping, resting-state fMRI correlation maps, and atlas-assisted segmentation. The submission module adds CT-to-MRI co-registration, automatic extraction of implanted deep brain stimulation lead geometry from CT, and display of the lead model with registered deep-brain structures as an adjunctive visualization aid. Some processing steps use locked machine-learning components described in an AI/ML Model Card. The source does not state performance testing results, clinical outcome data, or the model card contents.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Sep 10, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261795
Regulatory pathway
510(k) premarket notification
Product code
QIH
Decision code
SESE
Decision date
Sep 10, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Automated Radiological Image Processing Software.

Product code
QIH
FDA device class
2

FDA decision timeline

  1. K261795 received

    Application receipt date recorded by FDA.

  2. K261795 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QIH

Product / regulatory recordCompanyPathwayDecision dateSource
Clever OneK260372
Ewoosoft Co., Ltd.510(k) clearanceNov 4, 2026FDA
Peek Health, S.A.510(k) clearanceNov 4, 2026FDA
AVICENNA.AI510(k) clearanceOct 19, 2026FDA
UAB Ligence510(k) clearanceOct 7, 2026FDA
NeuroDRK262134
Deep Reasoning Ai, Inc.510(k) clearanceOct 7, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Omniscient Neurotechnology Pty, Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Haymarket

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records